Board of Nursing - an official New Hampshire Government website
Smaller text size Reset text size Larger text size
link to website translation page

COVID-19 Information and Resources

COVID-19 pharmacy practice related resources for Board licensees.

COVID-19 - Emergency Rules Adopted

  • Emergency Rules Adopted March 20, 2020
    • Ph 704.15, Ph 1303.01(b), Ph 1104.01(b) pdf file - Extending quantity of prescription drugs dispensed under certain circumstances; extending deadline for CPR certification for pharmacists engaged in the administration of vaccines.
  • Emergency Rules Adopted April 6, 2020
    • Ph 704.03(b)(4)d pdf file - Stating that during the pendency of the State of Emergency, pharmacists may accept a faxed-in prescription for a schedule II controlled drug. View Board Guidance Document pdf file and DEA Guidelines pdf file regarding these temporary emergency provisions during the COVID-19 crisis.
    • Ph 707.03, 707.04 pdf file - Stating that during the pendency of the State of Emergency, consulting pharmacists do not need pre-approval from the board to act as agents of the board for purposes of destruction of controlled drugs, so long as certain requirements are met. Also temporarily authorizes consulting pharmacists to witness the destruction of controlled substances remotely via videoconferencing.
  • Emergency Rule Adopted April 8, 2020
    • Ph 210 pdf file - Enabling Board to waive substantive rules as required during to COVID-19 crisis. The Board also issued a Standing Order pdf file to allow the Board to act quickly in deciding on waiver requests made under this rule.

COVID-19 - Executive Orders

COVID-19 - Federal DEA Controlled Drug Prescription Guidance - National State of Emergency

During this National Emergency the Diversion Control Division will continue to work with its Federal partners, DEA registrants, and their representative association to assure that there is an adequate supply of controlled substances in the United States. The DEA will also work to assure that patients will have access to controlled substances.

On March 16, 2020, the DEA published a COVID-19 Information Page on the Diversion Control Division Website. This page contains important guidance concerning COVID-19 and the national drug supply, electronic prescribing of controlled substances, telemedicine, medicated assisted treatment, and other important federal and state information. This site will be updated frequently as new information and guidance is issued. Please check back frequently for further information.

Please continue to direct all policy questions concerning COVID-19 to the Policy email box at

COVID-19 - News and Resources

Latest Information on the Coronoavirus (COVID-19) from the CDC and NH DHHS:

Portable Document Format Symbol Portable Document Format (.pdf). Visit for a list of free .pdf readers for a variety of operating systems.

Office of Professional Licensure and Certification
7 Eagle Square |  Concord, NH 03301
Main Telephone: (603) 271-2152